The Impact of Gender on Progression of Renal Disease: Potential Role of Estrogen-Mediated Vascular Endothelial Growth Factor Regulation and Vascular Protection

American Journal of Pathology

Volumn 164, Issue 2, 2004, Pages 679-688

  Kang, Duk Hee ^a,c   Yu, Eun Sun ^a   Yoon, Kyun Il ^a   Johnson, Richard ^b  

^a Ewha Womans University School of Medicine   (South Korea)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; MESSENGER RNA; NITRIC OXIDE DONOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ESTROGEN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DISEASE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; ENDOTHELIUM CELL; ESTROGEN ACTIVITY; FEMALE; GENDER; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; GROWTH REGULATION; HORMONAL REGULATION; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY MASS; LIPID BLOOD LEVEL; MALE; MICROANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEINURIA; RAT; SMOOTH MUSCLE FIBER; TREATMENT OUTCOME; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; KIDNEY; KIDNEY TUBULE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SEX DIFFERENCE; SPRAGUE DAWLEY RAT; VASCULARIZATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIVISION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTHELIAL CELLS; ESTROGENS; FEMALE; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; KIDNEY TUBULES; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SEX FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1542379706     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63155-0     Document Type: Article

References (35)

1. Silbiger SR, Neugarten J: The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 1995, 25:515-533
2. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000, 11:319-329
3. Dubey RK, Jackson EK: Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol 2001, 280:F365-F388
4. Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ: Impaired angiogenesis in the aging kidney: potential role of VEGF and TSP-1 in renal disease. Am J Kidney Dis 2001, 37:601-611
5. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model (I): potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 2001, 12:1434-1447
6. Kang D-H, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ: Role of endothelium in progressive renal disease. J Am Soc Nephrol 2002, 13:806-816
7. Kang DH, Nakagawa T, Feng L, Johnson RJ: Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol 2002, 161:239-248
8. Bunag RD, Butterfield J: Tail-cuff blood pressure measurement without external preheating in awake rats. Hypertension 1982, 4:898-903
9. Kim Y-G, Suga S, Kang D-H, Jefferson JA, Mazzali M, Gordon KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, Kerjaschki D, Schreiner GF, Johnson RJ: Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int 2000, 58:2390-2399
10. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model (II): VEGF administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 2001, 12:1448-1457
11. Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, Isner JM: Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 1997, 3:879-886
12. Munger K, Baylis C: Sex differences in renal hemodynamics in rats. Am J Physiol 1988, 254:F223-F231
13. Lombet JR, Adler SG, Anderson PS, Nast CC, Olsen DR, Glassock RJ: Sex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the rat. J Lab Clin Med 1989, 114:66-74
14. Silbiger SR, Neugarten J: The role of gender in the progression of renal disease. Adv Renal Replace Ther 2003, 10:3-14
15. Tolbert T, Oparil S: Cardiovascular effects of estrogen. Am J Hypertens 2001, 14:186S-193S
16. Elema JD, Arends A: Focal and segmental glomerular hyalinosis and sclerosis in the rat. Lab Invest 1975, 33:554-561
17. Kreisberg JI, Karnovsky MJ: Focal glomerular sclerosis in the fawn-hooded rat. Am J Pathol 1978, 92:637-652
18. Neugarten J, Gallo G, Silbiger S, Kasiske B: Glomerulosclerosis in aging humans is not influenced by gender. Am J Kidney Dis 1999, 34:884-888
19. Miller IJ, Suthanthiran M, Riggio RR, Williams JJ, Riehle RA, Vaughan ED, Stubenbord WT, Mouradian J, Cheigh JS, Stenzel KH: Impact of renal donation. Long-term clinical and biochemical follow-up of living donors in a single center. Am J Med 1985, 79:201-203
20. Hakim RM, Goldszer RC, Brenner BM: Hypertension and proteinuria: long-term sequelae of uninephrectomy in humans. Kidney Int 1984, 25:930-936
21. Antus B, Hamar P, Kokeny G, Szollosi Z, Mucsi I, Nemes Z, Rosivall L: Estradiol is nephroprotective in the rat remnant kidney. Nephrol Dial Transplant 2003, 18:54-61
22. Krasinski K, Spyridopoulos S, Asahara T, van der Zee R, Isner JM, Losordo DW: Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 1997, 95:1768-1772
23. Morey AK, Pedram A, Razandi M, Prins BA, Hu RM, Biesiada E, Levin ER: Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology 1997, 138:3330-3339
24. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, Kleinman HK, Schnaper HW: Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995, 91:755-763
25. Xiao S, Gillespie DG, Baylis C, Jackson EK, Dubey RK: Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth. Hypertension 2001, 37:645-650
26. Wang H, Keiser JA: Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ Res 1998, 83:832-840
27. Celletti FL, Waugh JM, Amabile PG, Brendolan A, Hilfiker PR, Dake MD: Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 2001, 7:425-429
28. 165 on progression of atherosclerotic plaque. J Am Coll Cardiol 2001, 37:2126-2130
29. Zeng H, Dvorak HF, Mukhopadhyay D: Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receotor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem 2001, 276:26969-26979
30. Suzuma I, Mandai M, Takagi H, Suzuma K, Otani A, Oh H, Kobayashi K, Honda Y: 17 Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci 1999, 40:2122-2129
31. Munger K, Baylis C: Sex differences in renal hemodynamics in rats. Am J Physiol 1988, 254:F223-F231
32. Baylis C: Renal effects of cyclooxygenase inhibition in the pregnant rat. Am J Physiol 1987, 253:F158-F163
33. Baylis C, Wilson CB: Sex and the single kidney. Am J Kidney Dis 1989, 13:290-298
34. Ellison KE, Ingelfinger JR, Pivor M, Dzau VJ: Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest 1989, 83:1941-1945
35. Manning JM, Edwards IJ, Wagner WD, Wagner JD, Adams MR, Parks JS: Effects of contraceptive estrogen and progestin on the atherogenic potential of plasma LDLs in cynomolgus monkeys. Arterioscler Thromb Vasc Biol 1997, 17:1216-1223